BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
38 results:

  • 1. Association of whsc1/nsd2 and T-cell infiltration with prostate cancer metastasis and prognosis.
    Li Q; Zhu J; Zhang Y; Pan Y; Li Z; Wang M; Gao Y; Feng D; He X; Zhang C
    Sci Rep; 2023 Dec; 13(1):21629. PubMed ID: 38062230
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Histone Methyltransferase nsd2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma.
    Chong PSY; Chooi JY; Lim JSL; Leow ACY; Toh SHM; Azaman I; Koh MY; Teoh PJ; Tan TZ; Chung TH; Chng WJ
    Cancer Res; 2023 Oct; 83(20):3414-3427. PubMed ID: 37463241
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mouse models of human multiple myeloma subgroups.
    Winkler W; Farré Díaz C; Blanc E; Napieczynska H; Langner P; Werner M; Walter B; Wollert-Wulf B; Yasuda T; Heuser A; Beule D; Mathas S; Anagnostopoulos I; Rosenwald A; Rajewsky K; Janz M
    Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2219439120. PubMed ID: 36853944
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
    Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
    JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of long noncoding RNA
    Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
    Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
    Fend F; Dogan A; Cook JR
    Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Posttranslational modification of Aurora A-nsd2 loop contributes to drug resistance in t(4;14) multiple myeloma.
    Jiang H; Wang Y; Wang J; Wang Y; Wang S; He E; Guo J; Xie Y; Wang J; Li X; Peng Z; Wang M; Hou J; Liu Z
    Clin Transl Med; 2022 Apr; 12(4):e744. PubMed ID: 35389552
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation.
    Wang J; Zhu X; Dang L; Jiang H; Xie Y; Li X; Guo J; Wang Y; Peng Z; Wang M; Wang J; Wang S; Li Q; Wang Y; Wang Q; Ye L; Zhang L; Liu Z
    J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166240
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Super Enhancer-Mediated Upregulation of
    Jia Y; Zhou J; Tan TK; Chung TH; Chen Y; Chooi JY; Sanda T; Fullwood MJ; Xiong S; Toh SHM; Balan K; Wong RWJ; Lim JSL; Zhang E; Cai Z; Shen P; Chng WJ
    Cancer Res; 2022 Feb; 82(3):406-418. PubMed ID: 34893510
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting nsd2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.
    Liu J; Xie Y; Guo J; Li X; Wang J; Jiang H; Peng Z; Wang J; Wang S; Li Q; Ye L; Zhong Y; Zhang Q; Liu X; Lonard DM; Wang J; O'Malley BW; Liu Z
    Nat Commun; 2021 Feb; 12(1):1022. PubMed ID: 33589584
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypoxia-induced CREB cooperates mmset to modify chromatin and promote DKK1 expression in multiple myeloma.
    Xu Y; Guo J; Liu J; Xie Y; Li X; Jiang H; Wang J; Peng Z; Wang J; Wang S; Wan C; Chen L; Zhong Y; Liu B; Liu Z
    Oncogene; 2021 Feb; 40(7):1231-1241. PubMed ID: 33420361
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Histone Mutations and bone cancers.
    Taylor EL; Westendorf JJ
    Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum Testosterone is Inversely and Sex Hormone-binding Globulin is Directly Associated with All-cause Mortality in Men.
    Yeap BB; Marriott RJ; Antonio L; Chan YX; Raj S; Dwivedi G; Reid CM; Anawalt BD; Bhasin S; Dobs AS; Hankey GJ; Matsumoto AM; Norman PE; O'Neill TW; Ohlsson C; Orwoll ES; Vanderschueren D; Wittert GA; Wu FCW; Murray K
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e625-e637. PubMed ID: 33059368
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
    Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
    Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evolution and structure of clinically relevant gene fusions in multiple myeloma.
    Foltz SM; Gao Q; Yoon CJ; Sun H; Yao L; Li Y; Jayasinghe RG; Cao S; King J; Kohnen DR; Fiala MA; Ding L; Vij R
    Nat Commun; 2020 May; 11(1):2666. PubMed ID: 32471990
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Histone methyltransferase nsd2 regulates apoptosis and chemosensitivity in osteosarcoma.
    He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
    Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells.
    Sankaran SM; Gozani O
    Epigenetics; 2017; 12(11):917-922. PubMed ID: 28933651
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
    Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
    Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. nsd2 promotes osteosarcoma cell proliferation and metastasis by inhibiting E-cadherin expression.
    Lu MH; Fan MF; Yu XD
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):928-936. PubMed ID: 28338204
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sabotaging of the oxidative stress response by an oncogenic noncoding RNA.
    Mahajan N; Wu HJ; Bennett RL; Troche C; Licht JD; Weber JD; Maggi LB; Tomasson MH
    FASEB J; 2017 Feb; 31(2):482-490. PubMed ID: 28148777
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.